Repository logo
 

Pro-inflammatory mediators sensitise transient receptor potential melastatin 3 cation channel (TRPM3) function in mouse sensory neurons.

Accepted version
Peer-reviewed

Loading...
Thumbnail Image

Change log

Authors

Abstract

Pro-inflammatory mediators can directly activate pain-sensing neurons, known as nociceptors. Additionally, these mediators can sensitise ion channels and receptors expressed by these cells through transcriptional and post-translational modulation, leading to nociceptor hypersensitivity. A well-characterised group of ion channels that subserve nociceptor sensitisation is the transient receptor potential (TRP) superfamily of cation channels. For example, the roles of TRP channels vanilloid 1 (TRPV1) and ankyrin 1 (TRPA1) in nociceptor sensitisation and inflammatory pain have been extensively documented. In the case of TRP melastatin 3 (TRPM3), however, despite the increasing recognition of this channel's role in inflammatory pain, the mediators driving its sensitisation during inflammation remain poorly characterised. Here, using Ca2+ imaging, we found that an inflammatory soup of bradykinin, interleukin 1β (IL-1β) and tumour necrosis factor α (TNFα) sensitised TRPM3 function in isolated mouse sensory neurons; IL-1β and TNFα, but not bradykinin, independently potentiated TRPM3 function. TRPM3 expression and translocation to the membrane remained unchanged upon individual or combined exposure to these inflammatory mediators, which suggests that post-translational modification might occur. Finally, using the complete Freund's adjuvant-induced model of knee inflammation, we found that systemic pharmacological blockade of TRPM3 does not alleviate inflammatory pain (as assessed through evaluation of digging behaviour and dynamic weight bearing), which contrasts with previous reports using different pain models. We propose that the nuances of the immune response may determine the relative contribution of TRPM3 to nociceptive signalling in different neuro-immune contexts. Collectively, our findings improve insight into the role of TRPM3 sensitisation in inflammatory pain.

Description

Journal Title

Neuropharmacology

Conference Name

Journal ISSN

0028-3908
1873-7064

Volume Title

Publisher

Elsevier

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
Pain Relief Foundation (Unknown)
MRC (MR/W002426/1)
Horizon Europe UKRI Underwrite MSCA (EP/X023117/1)
This work was principally funded by a Pain Relief Foundation research grant (J.A.-L. an E.St.J.S.). Furthermore, this work was partly supported by a joint and equal investment from UKRI and Versus Arthritis (MR/W002426/1) as part of the ADVANTAGE visceral pain consortium through the Advanced Pain Discovery Platform (APDP) initiative (J.A.L., L.A.P. and E.St.S.J.). T.K.L. acknowledges funding from UKRI Guarantee Marie Skłodowska-Curie Actions (MSCA) postdoctoral fellowship (EP/X023117/1). L.W.P. was funded by an AstraZeneca PhD studentship (G113502). Finally, the authors gratefully acknowledge the Cambridge Advanced Imaging Centre for their support and assistance in this work.